Citius Oncology Inc.CTORNASDAQ
Loading
Year-over-year research & development expense growth
Latest
30.32%
↑ 1358% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
2.08%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 30.32% |
| 2024 | 16.14% |
| 2023 | -38.15% |
| 2022 | 0.00% |